A new US research has suggested that people who take ibuprofen on regular basis may reduce their risk of developing Parkinson's disease.

The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research. They were questioned about their use of non-steroid anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen and acetaminophen.

The research was presented at the American Academy of Neurology's annual meeting in Toronto, Canada.

The result revealed that after a six year period, 293 participants had developed Parkinson's disease.

In addition, the study discovered that those who took ibuprofen on regularly were 40 per cent less prone to develop the disease than people who didn't take the drug, while, those consuming higher amounts of the drug were claimed to be at lower risk than those taking smaller levels of ibuprofen.

Xiang Gao, with Harvard School of Public Health in Boston quoted, "Other NSAIDs and analgesics, including aspirin and acetaminophen, did not appear to have any effect on lowering a person's risk of developing Parkinson's. More research is needed as to how and why ibuprofen appears to reduce the risk of Parkinson's disease".